Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amphastar Pharma (AMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 866,263
  • Shares Outstanding, K 45,980
  • Annual Sales, $ 255,170 K
  • Annual Income, $ 10,530 K
  • 36-Month Beta 1.51
  • Price/Sales 3.85
  • Price/Cash Flow 34.35
  • Price/Book 2.62

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.76 +14.56%
on 02/06/18
19.84 -3.23%
on 01/26/18
-0.19 (-0.98%)
since 01/23/18
3-Month
16.76 +14.56%
on 02/06/18
19.95 -3.76%
on 12/28/17
+0.30 (+1.59%)
since 11/22/17
52-Week
12.05 +59.34%
on 03/14/17
19.95 -3.76%
on 12/28/17
+4.39 (+29.64%)
since 02/23/17

Most Recent Stories

More News
Key Factors to Influence Penumbra's (PEN) Earnings in Q4

Penumbra (PEN) expects to gain from solid performance by neuro and peripheral vascular arms in Q4. Strong growth across all geographies is likely to drive the top line.

UHS : 116.41 (-0.26%)
PEN : 102.15 (+2.56%)
AMPH : 19.20 (+1.91%)
EXEL : 29.51 (+1.41%)
What's in Store for Veeva Systems (VEEV) in Q4 Earnings?

Consistent focus on Subscription Services is likely to drive Veeva Systems (VEEV) in Q4.

UHS : 116.41 (-0.26%)
VEEV : 61.55 (+2.86%)
AMPH : 19.20 (+1.91%)
EXEL : 29.51 (+1.41%)
Is a Beat in Store for Inogen (INGN) This Earnings Season?

Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.

UHS : 116.41 (-0.26%)
AMPH : 19.20 (+1.91%)
EXEL : 29.51 (+1.41%)
INGN : 131.15 (+1.28%)
Can PBM Unit Drive Express Scripts' (ESRX) Earnings in Q4?

Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.

UHS : 116.41 (-0.26%)
ESRX : 77.00 (+3.05%)
AMPH : 19.20 (+1.91%)
EXEL : 29.51 (+1.41%)
Abiomed's Extended FDA Nod for Impella Boosts Women Health

Abiomed (ABMD) boosts cardiomyopathy treatment with the extended FDA nod for Impella. This parallelly bolsters women's cardiac treatment.

ABMD : 268.45 (+1.70%)
ATHN : 139.88 (+1.20%)
BIVV : 104.74 (+0.42%)
AMPH : 19.20 (+1.91%)
CVS Health (CVS) Plans to Boost Hourly Minimum Wage Rate

CVS Health (CVS) raises minimum wage level on benefits earned from tax savings. The company plans to put the remaining savings back into the business.

CVS : 68.16 (+0.24%)
ATHN : 139.88 (+1.20%)
HCA : 100.84 (+0.30%)
AMPH : 19.20 (+1.91%)
5 Reasons to Invest in PerkinElmer (PKI) Stock Right Now

PerkinElmer (PKI) rides on synergies from the acquisition of EUROIMMUN and broadened product base.

ATHN : 139.88 (+1.20%)
HCA : 100.84 (+0.30%)
AMPH : 19.20 (+1.91%)
PKI : 77.02 (+1.40%)
Will Global Industrial Unit Aid Ecolab (ECL) in Q4 Earnings?

Ecolab's (ECL) strong segmental sales and acquisition-driven strategies are likely to drive fourth-quarter results.

COO : 230.54 (+1.13%)
AMPH : 19.20 (+1.91%)
ADRO : 6.60 (+6.45%)
ECL : 130.84 (+1.07%)
Henry Schein (HSIC) Q4 Earnings to Show Growth in All Lines?

Henry Schein (HSIC) likely to gain on strength across all business segments in Q4.

COO : 230.54 (+1.13%)
HSIC : 68.05 (+0.12%)
AMPH : 19.20 (+1.91%)
ADRO : 6.60 (+6.45%)
AmerisourceBergen (ABC) Gains on World Courier Unit Strength

AmerisourceBergen's (ABC) World Courier business gets GDP designation.

ABC : 98.42 (+1.34%)
HCA : 100.84 (+0.30%)
BIVV : 104.74 (+0.42%)
AMPH : 19.20 (+1.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

2nd Resistance Point 19.52
1st Resistance Point 19.36
Last Price 19.20
1st Support Level 18.91
2nd Support Level 18.62

See More

52-Week High 19.95
Last Price 19.20
Fibonacci 61.8% 16.93
Fibonacci 50% 16.00
Fibonacci 38.2% 15.07
52-Week Low 12.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.